Harisons Pharmaceuticals Limited
About Harisons Pharmaceuticals Limited
Data last updated:
Harisons Pharmaceuticals Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 June 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239CH1996PLC018334. Its GSTIN is 04AAACH7025F1Z2 (Chandigarh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Deepak Bajaj and Nanu Bajaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 62 Phase – Iiindustrial Area Chandigarh, Chandigarh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.48 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹60,736 (net margin 0.4%) and EBITDA of ₹91,083 (EBITDA margin 0.6%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹1.65 Cr and satisfied charges of ₹70 Lakh on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Harisons Pharmaceuticals Limited's registered office is in Chandigarh. Its e-mail address is in the company report.
- Email
- Registered Address62 Phase – Iiindustrial Area Chandigarh, Chandigarh, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Harisons Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Harisons Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Harisons Pharmaceuticals Limited, buy the company report.
Financials of Harisons Pharmaceuticals Limited
FY 2025 filings availableHarisons Pharmaceuticals Limited reported revenue of ₹1.48 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 7% fall in the latest year. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹91,083 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹60,736 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Harisons Pharmaceuticals Limited, buy the company report.
Board of directors of Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Bajaj | Director | 01 Jul 2002 | 24 Years 3 Months | Current |
| Nanu Bajaj | Director | 01 Jul 2002 | 24 Years 3 Months | Current |
| Dinesh Rawat | Director | 08 Nov 2012 | 13 Years 11 Months | Current |
Peer comparison
Harisons Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chemixl Intermediates Private Limited | ₹1.49 Cr (FY 2025) | -41.0% | Umargam, Gujarat, India | |||
| Native Drugs Private Limited | ₹1.49 Cr (FY 2025) | -20.0% | Amritsar, Punjab, India | |||
| Marvel Medilinks Private Limited | ₹1.48 Cr (FY 2024) | 4.0% | Punjab, India | |||
| Harisons Pharmaceuticals Limitedthis company | ₹1.48 Cr (FY 2025) | ₹60,736 | 0.4% | -7.0% | Chandigarh, India | |
| Simpha Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2016) | 182.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Harisons Pharmaceuticals Limited, buy the company report.
Auditor
Harisons Pharmaceuticals Limited is audited by SHAMSHER & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAMSHER & CO | FY 2020 | 017269N |
Shareholding
The shareholding of Harisons Pharmaceuticals Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Harisons Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Mar 2011 | 10280343 | Pumjab & Sind Bank | ₹1.25 Cr | Open | |
| 16 Aug 2005 | 80052698 | State Bank of India | ₹40 Lakh | Open | |
| 29 Jul 2009 | 10174890 | Indian Overseas Bank | ₹70 Lakh | Satisfied |
To see the full charge records of Harisons Pharmaceuticals Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Harisons Pharmaceuticals Limited has 5 court cases on record: 2 filed by Harisons Pharmaceuticals, 3 filed against it. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
| High courts | 2 | 0 | 0 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (2404-Indirect Taxation : Value Added Tax (VAT), State Sales Tax Act) | Filed against the company by Union Territory of Chandigarh THR. Its Finance Secretary 4Th Floor, U.T. Secretariat Building, Sector 9 , District: Chandigarh ,Chandigarh , Chandigarh and 3 others | Pending |
| High Court, CHANDIGARH (UT) | Writ petition | Filed by the company against individuals | Disposed |
| High Court, CHANDIGARH (UT) | Writ petition | Filed by the company against individuals | Disposed |
| District court, Sirsa, Haryana | Cheque dishonour complaint | Filed against the company by an individual | Disposed |
| District court, Jalandhar, Punjab | Commercial suit | Filed against the company by an individual | Disposed |
To see the full case history of Harisons Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Harisons Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Harisons Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAACH7025F1Z2 | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Harisons Pharmaceuticals Limited, buy the company report.
Recent activity
Harisons Pharmaceuticals Limited has 4 board changes on record since 2002: 3 appointments and 1 cessation. The latest: Balwant Rai Bajaj ceased to be Director on 08 Nov 2012.
Frequently asked questions
Harisons Pharmaceuticals is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 June 1996 (30+ years old) and is registered under CIN U24239CH1996PLC018334.
Harisons Pharmaceuticals has 3 current directors:
- Deepak Bajaj - Director
- Nanu Bajaj - Director
- Dinesh Rawat - Director
The latest financial statements of Harisons Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Harisons Pharmaceuticals is 04AAACH7025F1Z2, registered in Chandigarh.
The CIN (Corporate Identification Number) of Harisons Pharmaceuticals is U24239CH1996PLC018334. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Harisons Pharmaceuticals has 5 court cases on record: 2 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.
Harisons Pharmaceuticals was incorporated on 13 June 1996, making it 30+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Harisons Pharmaceuticals by revenue are Chemixl Intermediates Private Limited, Native Drugs Private Limited, Marvel Medilinks Private Limited, Simpha Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Balwant Rai Bajaj ceased to be Director on 08 Nov 2012. Dinesh Rawat was appointed as Director on 08 Nov 2012. Deepak Bajaj was appointed as Director on 01 Jul 2002. Harisons Pharmaceuticals has 4 board changes on record in total.
The registered office of Harisons Pharmaceuticals is at 62 Phase – Iiindustrial Area Chandigarh, Chandigarh, India.
Harisons Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.